BTS guideline for the investigation and management of malignant pleural mesothelioma

BTS guideline for the investigation and management of malignant pleural mesothelioma

The full guideline for the investigation and management of malignant pleural mesothelioma is published in Thorax. The following is a summary of the recommendations and good practice points. The sections referred to in the summary refer to the full guideline.

Bibliographic Details
Main Authors:	Woolhouse, I, Bishop, L, Darlison, L, de Fonseka, D, Edey, A, Edwards, J, Faivre-Finn, C, Fennell, D, Holmes, S, Kerr, K, Nakas, A, Peel, T, Rahman, N, Slade, M, Steele, J, Tsim, S, Maskell, N
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2018

Similar Items

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
by: Woolhouse, I, et al.
Published: (2018)

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
by: Bibby, A, et al.
Published: (2016)

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
by: Duneesha De Fonseka, et al.
Published: (2022-04-01)

An inconvenient truth concerning surgery for mesothelioma
by: De Fonseka, D, et al.
Published: (2018)

Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial)
by: De Fonseka, D, et al.
Published: (2018)

BTS guidelines for the management of pleural infection
by: Davies, C, et al.
Published: (2003)

BTS guidelines for the management of pleural infection.
by: Davies, C, et al.
Published: (2003)

Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
by: Alex Dipper, et al.
Published: (2021-06-01)

The association between pleural fluid exposure and survival in pleural mesothelioma
by: Asciak, R, et al.
Published: (2021)

BTS guidelines for the management of pleural infection - Reply
by: Davis, R, et al.
Published: (2004)

Prognostication and monitoring of mesothelioma using biomarkers: a systematic review
by: Arnold, D, et al.
Published: (2017)

Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)

Malignant pleural mesothelioma: an update
by: Glaucia N. M. Hajj, et al.
Published: (2021-12-01)

Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
by: Liz Darlison, et al.
Published: (2022-02-01)

Extrathoracic Metastases in Pleural Mesothelioma
by: Ibiayi Dagogo-Jack, MD, et al.
Published: (2023-09-01)

Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma
by: Lim, E, et al.
Published: (2020)

Malignant pleural mesothelioma with resolution of pleural effusion
by: Sayaka Nishida, et al.
Published: (2023-11-01)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
by: Claudio Sorino, et al.
Published: (2023-11-01)

Pleural abnormalities predating the development of mesothelioma
by: Hassan, M, et al.
Published: (2017)

Sarcopenia and Pleural Mesothelioma: The Current Knowledge
by: Nikolaos D. Karakousis, et al.
Published: (2024-02-01)

Pleural mesothelioma metastasis of the scalp
by: Tugcem Bicak, et al.
Published: (2024-02-01)

Pleural Mesothelioma in the Era of Immunotherapy
by: Mathieu Chevallier, et al.
Published: (2023-07-01)

Immunotherapy in Malignant Pleural Mesothelioma
by: Cornedine J. de Gooijer, et al.
Published: (2020-02-01)

Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
by: Agnes Y. Choi, et al.
Published: (2022-05-01)

Pleural diseases: saline irrigation in pleural infection, epidemiology of pneumothorax, and bevacizumab in mesothelioma
by: Corcoran, J, et al.
Published: (2017)

KRAS signaling in malignant pleural mesothelioma
by: Antonia Marazioti, et al.
Published: (2022-02-01)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
by: Rita Terenziani, et al.
Published: (2021-06-01)

Malignant pleural mesothelioma in a child
by: Jed Brendan Scharf, et al.
Published: (2015-10-01)

Advances in Immunotherapy for Malignant Pleural Mesothelioma
by: Yujia CHI, et al.
Published: (2022-04-01)

Duodenal Metastasis of Malignant Pleural Mesothelioma
by: Huang-Chi Chen, et al.
Published: (2008-12-01)

Pleural amyloidosis mimicking malignant mesothelioma
by: Min Yeong Kim, et al.
Published: (2017-06-01)

Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016-05-01)

Pleural tuberculosis mimicking malignant mesothelioma
by: Wajahat Dawood, et al.
Published: (2020-01-01)

Circulating biomarkers in malignant pleural mesothelioma
by: Giuseppe Viscardi, et al.
Published: (2020-12-01)

Diagnosis and Treatment of Malignant Pleural Mesothelioma
by: Zhilong ZHAO, et al.
Published: (2009-01-01)

Pleural Mesothelioma in a young male patient
by: A. Voulgaridis, et al.
Published: (2015-11-01)

Phase II study of vinflunine in malignant pleural mesothelioma.
by: Talbot, D, et al.
Published: (2007)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
by: Davis A, et al.
Published: (2022-03-01)

Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
by: Jenette Creaney, et al.
Published: (2022-05-01)

Clinical staging of malignant pleural mesothelioma: current perspectives
by: Bonomi M, et al.
Published: (2017-08-01)